Jinhua Xinwang International Trade Co., Ltd. – Trademark Portfolio

Entity Type: 16

Jinhua Xinwang International Trade Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LUMINARY AETHER. The owner is based in Yiwu City, Zhejiang Province.

Room 102, 1st Floor

No. 67, Donghumen, Suxi Town

Yiwu City, Zhejiang Province 322000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Jinhua Xinwang International Trade Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Jinhua Xinwang International Trade Co., Ltd. have?

Jinhua Xinwang International Trade Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Jinhua Xinwang International Trade Co., Ltd. file in?

Jinhua Xinwang International Trade Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Jinhua Xinwang International Trade Co., Ltd.'s most well-known trademarks?

Jinhua Xinwang International Trade Co., Ltd.'s registered trademark portfolio includes well-known marks such as LUMINARY AETHER. These are among 1 currently registered trademark in the portfolio.

What is Jinhua Xinwang International Trade Co., Ltd.'s trademark registration success rate?

Jinhua Xinwang International Trade Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.